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Hearing-Impaired Children in the United Kingdom,
IV: Cost-Effectiveness of Pediatric
Cochlear Implantation
Garry R. Barton, Paula C. Stacey, Heather M. Fortnum, and A. Quentin Summerfield
Objective: To estimate the cost-effectiveness of pe-
diatric cochlear implantation by conducting a cost-
utility analysis from a societal perspective.
Design: In a cross-sectional survey, the parents of a
representative sample of hearing-impaired chil-
dren assessed the health utility of their child using
a revised version of the Health Utilities Index Mark
III questionnaire. Linear regression was used to
estimate the gain in health utility associated with
implantation while controlling for eight potentially
confounding variables: average (4-frequency, un-
aided, preoperative) hearing level (AHL), age at
onset of hearing-impairment, age, gender, number
of additional disabilities, parental occupational
skill level, ethnicity, and parental hearing status.
The gain in health utility was accumulated to esti-
mate the number of quality-adjusted life years
(QALYs) that would be gained from implantation
over 15 yr and over a child’s lifetime. The incremen-
tal societal cost of implantation, calculated in euros
(€) at 2001/2 levels, was estimated by summing the
incremental costs of implantation that are incurred
in the health sector, in the education sector, and by
the child’s family. The cost-effectiveness of cochlear
implantation was estimated by calculating the in-
cremental societal cost per QALY gained and was
compared with an upper limit of acceptability of
€50,000 per QALY.
Results: The parents of 403 implanted children, and
1863 nonimplanted children, completed the health
utility questionnaire. Higher health utility was as-
sociated with a more favorable AHL, an older age at
onset of hearing impairment, female gender, having
fewer additional disabilities, having parents with a
greater occupational skill level, white ethnicity,
and implantation. The gain in health utility associ-
ated with implantation was estimated to be higher
for children with a worse preoperative AHL and
who were implanted when younger. Over 15 yr, for
a child implanted at age 6 with a preoperative loss
of 115 dB, 2.23 QALYs were estimated to be gained,
compared with a mean incremental societal cost of
€57,359, yielding a mean cost per QALY of €25,629.
Cost-effectiveness was more favorable: (1) when
estimated over a child’s lifetime rather than 15 yr,
(2) for children with a worse preoperative AHL, and
(3) for children who were implanted when younger.
Conclusions: The mean cost of gaining a QALY for
the children in the present sample falls within
acceptable limits. The strategy of giving highest
priority for implantation to children with the great-
est loss of hearing, and who are younger, maximizes
benefit for a given cost.
(Ear & Hearing 2006;27;575–588)
Resources in health services are scarce. Accord-
ingly, the cost-effectiveness of health care inter-
ventions should be scrutinized to enable resources
to be allocated so as to maximize effectiveness (i.e.,
the benefit received by patients) for a given cost. The
effectiveness of health-care interventions can be
measured in the common metric of health utility,
where more preferable states of health have higher
values, with a value of zero corresponding to death
and a value of one corresponding to perfect health
(Drummond, O’Brien, Stoddart & Torrance, 1997;
Gold, Siegel, Russell, & Weinstein, 1996). This ge-
neric approach enables the benefits of interventions
for different conditions to be compared on the same
scale. By accumulating the gain in health utility
associated with an intervention over time, the num-
ber of quality adjusted life years (QALYs) that will
be received from the intervention over that time
period can be estimated (Drummond et al., 1997;
Torrance & Feeny, 1989). Cost-effectiveness can
then be calculated as the cost of gaining a QALY
(cost/QALY). Interventions which gain QALYs at
lower cost are judged to be more cost-effective than
interventions which gain QALYs at higher cost.
The primary aim of the study reported in this
paper was to estimate the cost-effectiveness of pro-
viding cochlear implants to children. A secondary
aim was to examine differences in cost-effectiveness
between different groups of candidates for implan-
tation. Justification for this secondary aim is pro-
vided by evidence that the clinical and demographic
characteristics of children influence many outcomes
from implantation, including speech perception (e.g.,
Miyamoto, Osberger, Robbins,Myres, &Kessler, 1993;
Stacey, Fortnum, Barton, & Summerfield, 2006; Tyler,
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Fryauf–Bertschy, Gantz, Kelsay, &Woodworth, 1997),
spoken language, auditory performance, speech intel-
ligibility, academic abilities (Stacey, et al., 2006), and
the cost of education (Barton, Stacey, Fortnum, &
Summerfield, 2006a; Schulze–Gattermann, Illg,
Schoenermark, Lenarz, & Lesinski–Schiedat, 2002). It
is possible therefore that the cost-effectiveness of im-
plantation also varies according to the characteris-
tics of the child. We focus on three characteristics
which have previously been shown to exert a posi-
tive influence on the benefit associated with implan-
tation: a younger age at implantation (Kileny,
Zwolan, & Ashbaugh, 2001; Kirk, Miyamoto, Lento,
Ying, O’Neill, & Fears, 2002; Miyamoto, et al., 1993;
Nikolopoulos, O’Donoghue, & Archbold, 1999;
Sharma, Dorman, & Spahr, 2002; Stacey, et al.,
2006; Svirsky, Teoh, & Neuburger, 2004; Tyler, et
al., 1997), a greater duration of implant use (Stacey,
et al., 2006; Tyler, et al., 1997), and a poorer preop-
erative average hearing level (AHL) (Stacey, et al.,
2006; Tyler, et al., 1997). If the cost-effectiveness of
implantation varied with any of these variables,
then it could be more cost-effective to implant some
groups of children than others (e.g., younger chil-
dren in preference to older children, or children with
less favorable AHLs in preference to children with
more favorable AHLs). Given that the number of
implants funded each year is restricted both in the
United Kingdom and elsewhere (Summerfield, Sta-
cey, Roberts, Fortnum, & Barton, 2003), evidence of
cost-effectiveness could guide the allocation of re-
sources among candidates for cochlear implants. In
this way, priority could be given to candidates who
are expected to receive the greatest benefit for a
given cost.
Several studies have used measures of health
utility to assess the cost-effectiveness of pediatric
cochlear implantation (Cheng, Rubin, Powe, Mellon,
Francis, & Niparko, 2000; Hutton, Politi, & Seeger
1995; O’Neill, O’Donoghue, Archbold, & Normand,
2000; Summerfield & Marshall, 1995; Summerfield,
Marshall, & Archbold, 1997; Wyatt, Niparko, Rothman,
& De Lissovoy, 1995). All of these studies concluded
that pediatric implantation was acceptably cost-
effective, but none estimated how cost-effectiveness
varied among candidates. We estimated this varia-
tion, and were guided by two studies of speech-
perception outcomes from implantation. The first
suggests that the cost-effectiveness of implantation
is likely to be better when children are implanted
younger (O’Neill, O’Donoghue, Archbold, Nikolopou-
los, & Sach, 2002) and, the second, that cost-effec-
tiveness improves with time after implantation (Sach,
O’Neill, Whynes, Archbold, & O’Donoghue, 2003).
Only one study (Cheng et al., 2000) based the
measure of effectiveness on health-utility data for
children. Other studies (e.g., Hutton et al., 1995;
O’Neill et al., 2000; Summerfield, & Marshall, 1995;
Summerfield et al., 1997) inferred the gain in utility
for children from the gain measured with adults,
which may be inappropriate because the effect of
implantation for prelingually deafened children may
differ in kind and degree from the effect for postlin-
gually deafened adults (Summerfield & Marshall,
1995; Cheng et al., 2000). Cheng et al. (2000) asked
the parents of 78 children who had received im-
plants in a single hospital in the United States to
judge, retrospectively, what their children’s health
utility had been before implantation and to judge
how it was currently after implantation. The gain in
utility associated with implantation was estimated
by subtracting the retrospective score from the cur-
rent score. Three methods were used to measure
health utility: (i) the Health Utilities Index Mark III
(HUI3) questionnaire (Feeny, Furlong, Boyle, &
Torrance, 1995; Feeny, Furlong, Torrance, Gold-
smith, Zhu, De Pauw, Denton, & Boyle, 2002), (ii) a
visual analogue scale (Torrance, Feeny, & Furlong,
2001), and (iii) the time trade-off (TTO) technique
(Torrance, 1986). The mean changes in utility were
(i) 0.39, (ii) 0.27, and (iii) 0.22. After discount-
ing future benefits (as discussed later in this paper),
the number of QALYs that would be gained from
cochlear implantation over a child’s lifetime was
estimated to be (i) 11.59, (ii) 8.03, and (iii) 6.54.
When assessed in relation to medical reimburse-
ment costs in the United States, the cost/QALY was
(i) US $5200, (ii) US $7400, and (iii) US $9000 (1999
price levels, Footnote 1).
These values were judged to be strongly compet-
itive when compared with the cost/QALY of other
health-care interventions. Using educational cost
data reported by Francis, Koch, Wyatt, and Niparko
(1999), Cheng et al. (2000) estimated that implanta-
tion would reduce the cost of school education by US
$65,588. This saving, coupled with other costs out-
side the health service, including an estimated in-
crease in future earnings of US $55,574, meant that
pediatric cochlear implantation was predicted to
result in a net cost saving for US society of US
$53,198 per child implanted. Accordingly, it was
judged that pediatric cochlear implantation was a
cost-effective intervention both when assessed in the
health domain, and when assessed from a broader
societal perspective.
1 The average exchange rate between the US dollar and the euro
(€) was US $1.00  €0.8851 in the calendar year 2003 (Bank of
England 2004, Reference Note 1). To aid comparisons, we report
costs estimated in previous studies in the currency in which they
were originally reported and state the year on which cost analy-
ses were based.
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The study reported by Cheng et al. (2000) had
three potential limitations. First, estimates of the
gain in health utility were collected retrospectively
and thus may have been subject to recall bias
(Dawson, Kanim, Sra, Dorey, Goldstein, Delamarter,
& Sandhu, 2002). Second, estimates were based on a
small number of children (up to 78 in the health
sector, and 27 in the education sector) who were
implanted in the same hospital. As such, it is not
clear how far the results can be generalized (Dans,
Dans, Guyatt, & Richardson, 1998; Johnston,
Buxton, Jones, & Fitzpatrick, 1999). In addition, the
small sample size meant it was not possible to assess
how the cost-effectiveness of implantation varied
between children with different characteristics. Third,
the health-service costs of implantation were based on
reimbursement levels rather than actual costs. Reim-
bursement levels do not always provide a good esti-
mate of the true cost of the resources consumed in
providing heath care (Beck, Beecham, Mandalia,
Griffith, Walters, Boulton, & Miller, 1999), and there
is evidence that the level of public reimbursement for
cochlear implantation in the United States is often
below cost (Cheng & Niparko, 1999; Garber, Ridgely,
Bradley & Chin, 2002).
We addressed these limitations by undertaking
a cross-sectional survey in which data for a large
representative sample of children were collected
(Fortnum, Stacey, & Summerfield, in press). We
estimated the gain in health utility associated
with cochlear implantation by comparing the im-
planted and nonimplanted members of the sam-
ple, while controlling the influence of other
variables that differ between implanted and non-
implanted children (i.e., while controlling poten-
tially confounding influences on health utility).
We accumulated the gain in health utility to
estimate the number of QALYs that would be
obtained from implantation. This number was
assessed in relation to estimates of the incremen-
tal cost to society of providing implantation. The
incremental cost is the additional cost of providing
implants over and above the cost of management
with acoustic hearing aids. To obtain a societal
perspective, the incremental cost was estimated as
the combination of components incurred in the
health sector (Barton, Bloor, Marshall, & Summer-
field, 2003), the education sector (Barton, et al.,
2006a), and by the child’s family (Barton, Fortnum,
Stacey, & Summerfield, 2006b). The third compo-
nent was composed of out-of-pocket expenditure and
lost productivity associated with time away from
normal activities by parents.
In the UK, the National Institute for Health and
Clinical Excellence (NICE) takes cost-effectiveness
data into account in issuing mandatory guidance on
which health technologies should, and which should
not, be provided in the publicly funded health sector.
Initial interpretations of NICE’s judgments (e.g.
Raftery, 2001) concluded that interventions that
gained QALYs for more than about €50,000 were
unlikely to be approved. More recent interpretations
have concluded that cost-effectiveness is only one of
several variables that predict whether an interven-
tion will be approved (Dakin, Devlin, & Odeyemi,
2006) and that the cost-effectiveness boundary is
gradual rather than abrupt, such that the threshold
beyond which interventions are unlikely to be
funded is in the range from €38,000/QALY to
€77,000/QALY (Devlin & Parkin, 2004). Nonethe-
less, for purposes of discussion it is useful to adopt
categorical criteria. We infer that interventions that
cost less than about €15,000 per QALY offer good
value for money, that interventions that cost be-
tween €15,000 and €50,000 per QALY offer accept-
able value for money, and that interventions that
cost more than about €50,000 per QALY offer ques-
tionable value for money. We assessed the cost-
effectiveness of cochlear implantation for different
groups of children in relation to these criteria.
The cost-effectiveness of cochlear implantation
was assessed over two time periods: (i) 15 yr, and (ii)
the child’s lifetime. In line with Barton et al. (2003),
we judged that 15 yr is the minimum length of time
for which implants will be used by children before
being superseded by new interventions. A child’s
lifetime is the maximum period over which the costs
and benefits of cochlear implantation could accrue,
and is the period incorporated in previous estimates
of the cost-effectiveness of pediatric cochlear im-
plantation (Cheng et al., 2000; Hutton et al., 1995;
O’Neill et al., 2000; Summerfield & Marshall, 1995;
Summerfield et al., 1997; Wyatt et al., 1995).
METHODS
Overview
The cost-effectiveness of pediatric implantation
was estimated using two values. The first was the
incremental societal cost of implantation, which is
the difference in cost to society between implanta-
tion and alternative interventions. The second was
the gain in health utility associated with implanta-
tion compared with alternative interventions, which
in turn allowed the number of QALYs gained from
implantation to be estimated.
Participants and Procedures
Fortnum, Summerfield, Marshall, Davis, and
Bamford (2001) ascertained the population of chil-
dren in the United Kingdom with permanent bilat-
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eral hearing impairment 40 dB HL in the better
hearing ear. They identified 17,160 children. We
undertook a cross-sectional survey, in which the
parents of a sample of 8876 of these children were
invited to consent for themselves, their child’s school
teacher, and their child’s audiologist to participate
in the present study by completing postal question-
naires about their child. The sample included all
children with cochlear implants (N  993), all other
profoundly impaired (AHL 95 dB) children (N 
3288), all severely impaired (AHL 71–95 dB) chil-
dren (N  3580), and a stratified random sample of
approximately one in nine of the moderately im-
paired (AHL 41–70 dB) children (N  1015). Sub-
sampling the moderately impaired children was
desirable for practical reasons, given the large num-
ber of children with a moderate hearing impair-
ment. The parents’ questionnaire obtained data
which enabled the health utility of children to be
estimated, as described below. Values of nine other
variables (Table 1) with the potential to explain
variation in a child’s health utility were obtained
from the questionnaires completed by parents,
teachers, and audiologists, as described by Stacey et
al. (2006).
Health Utility
Self-completion questionnaires, in which a person
describes their status in different health domains,
are the most commonly used method for estimating
health utility scores (Brazier, Deverill, Green, Harper, &
Booth, 1999). Such questionnaires are designed to
obtain a description of a person’s health state. A
utility score is then assigned to that state, based on
preferences previously elicited from members of the
general public (Feeny et al., 2002).
In the present study, estimates of the health
utility of children were obtained by proxy from
parents with a modified version of the HUI3 ques-
tionnaire. The HUI3 questionnaire (Feeny et al.,
1995; Feeny et al., 2002) measures a person’s capac-
ity to function in eight domains related to vision,
hearing, speaking (and being understood), mobility,
dexterity, emotion, cognition, and pain. Some ques-
tions in the standard HUI3 questionnaire are con-
ceptually and linguistically complex. For example,
in the section on pain, the response options combine
three concepts: the frequency and intensity of pain
and discomfort; the degree of disruption to normal
activities; and the extent to which discomfort is
relieved by drugs. After obtaining feedback from
parents, we changed the wording of some questions
so that they would be more easily understood by
English speakers in the United Kingdom, and also
simplified some questions by decomposing the issues
which they addressed into separate questions. This
revised version of the HUI3 questionnaire was embed-
ded within the parents’ questionnaire (MRC Institute
of Hearing Research, Reference Note 2). The revised
response options permitted a straightforward map-
ping onto the response options in the original question-
naire. Thus, the standard HUI3 scoring algorithm
(Feeny et al., 2002) could be used to estimate the
health utility of each child. The mean health utility,
and associated 95% confidence interval (95% CI), was
calculated for nonimplanted children with different
hearing losses and for implanted children.
Gain in Health Utility • The gain in health
utility associated with implantation was estimated
using linear regression. This form of analysis predicts
a dependent variable using a weighted sum of the
values of a set of explanatory variables. Each weight
TABLE 1. Explanatory variables tabulated for each child
Variable Values
1. Average unaided (preoperative) hearing level (AHL) Unaided pure-tone air-conduction thresholds in the better-hearing ear
averaged across the four frequencies 0.5, 1, 2, and 4 kHz.
2. Age at onset of hearing impairment (AONS) (i) At birth, (ii) Between the ages of 0 and 3 yr, (iii) After 3 yr of age.
3. Age (AGE) Age in years on date questionnaire was returned.
4. Gender (GEND) (i) Male, (ii) Female.
5. Number of additional disabilities (NDIS) (i) None, (ii) One, (iii) Two or more.
6. Parental occupational skill level (POSL) Classification of the level of skill entailed in the parent’s job, ranging from
(lowest to highest) (i) Level 1, (ii) Level 2, (iii) Level 3, (iv) Level 4.
7. Ethnicity (ETHN) (i) White, (ii) Other.
8. Parental hearing status (PHS) (i) No hearing difficulties, (ii) At least some difficulties.
9. Cochlear implantation (CI) (categorized according to Group Age at implantation Duration of use
age at implantation and duration of implant use) (1) 5 yr 4 yr
(2) 5 yr 4 yr
(3) 5 yr 2, 4 yr
(4) 5 yr 2, 4 yr
(5) 5 yr 2 yr
(6) 5 yr 2 yr
(7) nonimplanted nonimplanted
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(coefficient) is an estimate of the association between
the dependent variable and an explanatory variable,
while controlling the strength of association between
the dependent variable and each of the other explan-
atory variables (e.g. Strube, 2003). Where the 95% CI
of a coefficient does not embrace zero, the correspond-
ing explanatory variable makes a significant indepen-
dent contribution to explaining variance in the depen-
dent variable (i.e., is statistically significant).
We used linear regression to estimate the extent
to which health utility could be predicted by the nine
explanatory variables in Table 1: AHL (Footnote 2),
age at onset of hearing-impairment, age, gender,
number of additional disabilities, parental occupa-
tional skill level, ethnicity, and parental hearing
status and cochlear implantation. The latter vari-
able was a seven-valued factor that distinguished
non-implanted children from six groups of im-
planted children formed by the intersection of two
ages at implantation, 5 yr, and 5 yr, and three
durations of use of implants, 2 yr, 2 to 4 yr, and
4yr. The coefficients for each group of implanted
children provided an estimate of the gain in utility
for that group. It is an assumption of linear regres-
sion analysis that continuous variables vary linearly
with the dependent variable. Accordingly, before
conducting the analysis, age and AHL were trans-
formed to vary linearly with utility using the meth-
ods described by Stacey et al. (2006) (Footnote 3).
Two other continuous measures, age at onset of
hearing impairment and the number of additional
disabilities, had skewed distributions. These mea-
sures were converted into categorical variables.
Two analyses were performed. The first was de-
scriptive. It determined whether there was a signif-
icant association between implantation and health
utility when the other explanatory variables in Ta-
ble 1 were controlled. The second analysis estab-
lished how the relationship between implantation
and health utility differed according to the AHL of
implanted children. This second analysis included
an interaction term between AHL and cochlear
implantation (i.e., the coefficient for AHL was al-
lowed to differ, depending on whether children were
implanted or nonimplanted) (Footnote 4). Further
details of this approach, and examples of its use, are
provided by Stacey et al. (2006) and Barton et al.
(2006a). Analyses were performed with the SAS
system (Freund & Littell, 2000).
Incremental Costs
Health Sector • Barton et al. (2003) measured
the costs incurred by the UK National Health Ser-
vice in providing implants to children in 12 pediatric
cochlear implant programs. The incremental health
sector cost of implantation was estimated by deduct-
ing an estimate of the costs that would have been
entailed in providing acoustic hearing aids to the
children. The analysis yielded an estimate of the
average incremental cost of managing a child in
each “year of care,” starting with the year leading up
to and including implantation. Barton et al. (2003)
did not investigate whether costs vary according to
age at implantation or preoperative AHL. Accord-
ingly, the average incremental cost was assumed to
apply to all implanted children. Costs, which were
reported by Barton et al. (2003) at 2000/1 levels,
2 The abbreviation, AHL, is used in this article to refer to the
average of pure-tone air-conduction thresholds at the frequencies
0.5, 1, 2, and 4 kHz in the better-hearing ear. In the case of
nonimplanted children, AHL refers to unaided hearing levels. In the
case of implanted children, AHL refers to preoperative unaided
hearing levels. In the children in the present study, AHL is related
to the three-frequency pure-tone average (PTA) computed at
500 Hz, 1 kHz, and 2kHz by the equation: PTA  –0.86 
0.98  AHL. Thus, AHLs between 95 and 125 dB HL correspond to
PTAs between 93 and 122 dB HL.
3 The explanatory variables in Table 1 include covariates (the
continuous variables, AGE and AHL) and factors (the other
variables which are categorical). Utility scores did not vary
systematically with AGE. Therefore, AGE was not transformed.
Utility scores did vary with AHL. After exploring several func-
tions, an exponential function was chosen to transform AHL to
vary linearly with health utility:
AHL’  –0.38/(1  e(–(AHL – 98.79)/9.32)).
4 The linear equation obtained from the first descriptive regres-
sion analysis took the form:
Uw0w1(if GEND “Female”)w2 AGEw3(if ETHN
 “White”)  w4(if PHS  “No hearing difficulties”)  w5
 AHL’  w6,1(if AONS  “Between the ages of 0 and 3 yr”)
 w6,2(if AONS  “After 3 yr of age”)  w7,1(if NDIS
 “One”)  w7,2(if NDIS  “Two or more”)  w8,1(if POSL
 “Level 4”)  w8,2(if POSL  “Level 3”)  w8,3(if POSL
 “Level 2”)  w9,1(if CI  “Group 1”)  w9,2(if CI
 “Group 2”)  w9,3(if CI “Group 3”)  w9,4(if CI
 “Group 4”)  w9,5(if CI “Group 5”)  w9,6(if CI
 “Group 6”)
where U is health utility, w0 to w9 are (constant) coefficients, and
the strings of upper-case letters are the abbreviations for the
explanatory variables defined in Table 1. Coefficients are inter-
preted differently depending on whether they weight a covariate
or a factor. w2 and w5 are the differences in health utility
associated with a unit change in AGE and AHL’ (the transformed
value of AHL). The other coefficients are the differences in health
utility associated with possession of one value of a factor rather
than another. Thus, for example, w9,1 is the difference in health
utility between a child with an implant in Group 1 and a child
who is similar in respect of all other explanatory variables but
who does not have an implant.
The linear equation obtained from the second regression anal-
ysis had the same form as the equation above, with the additional
term:
[w10,1 AHL’ (if CI “Group 1”) w10,2 AHL’ (if CI  “Group 2”)
 w10,3  AHL’ (if CI  “Group 3”)  w10,4  AHL’ (if CI
 “Group 4”)  w10,5  AHL’ (if CI  “Group 5”)  w10,6
 AHL’ (if CI  “Group 6”)].
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were inflated to 2001/2 levels using the Hospital and
Community Health Services Pay and Prices Index
(National Health Service Executive, 2004) to ensure
compatibility with the cost levels for education and
the family.
Education Sector • The teachers’ questionnaire,
used in the present study, obtained the school place-
ment of each child and the level of support received
by the child in that placement because of the child’s
impaired hearing. Barton et al. (2006a) combined
these data with the costs of placing and supporting
hearing-impaired children in different educational
settings to estimate the annual cost of education of
each child.
Economic Costs Incurred by the Family • The
parents’ questionnaire, used in the present study,
obtained data on annual resources used by the
family because of their child’s impaired hearing in
two areas: (i) out-of-pocket expenditure, and (ii) time
away from usual activities by parents in accompa-
nying children to clinic and hospital appointments.
Barton et al. (submitted) summed the cost of each of
these two resources to obtain an estimate of the
overall economic cost incurred by each child’s family.
The data for the annual education cost and overall
economic cost incurred by the family were analyzed
using linear regression, in the same style as the
analyses of health utility, describe above. The analyses
yielded estimates of the annual education cost and of
the overall economic cost incurred by families associ-
ated with each variable in Table 1. The cumulative
education cost associated with implantation (up to the
age of 16 yr) and the cumulative economic cost in-
curred by the families of implanted children (up to the
age of 16 yr) were also calculated.
Accumulating Utility and Costs
The number of QALYs gained from implantation
was calculated by summing the gain in health utility
associated with implantation in each year of care.
The gain for children who had been implanted for
less than 2 yr was taken as the estimate of the gain
in the first year and second year after implantation.
The corresponding gain for children who had been
implanted for between 2 and 4 yr was taken as the
estimate of the gain in the third year and fourth
year after implantation. The corresponding gain for
children who had been implanted for more than 4 yr
was taken as the estimate of the gain in the fifth
year and each subsequent year after implantation.
The incremental health sector costs of implanta-
tion were estimated by deducting the cost of alter-
native treatments (as estimated by Summerfield,
Marshall, Barton, & Bloor, 2002) from the health
sector costs of pediatric cochlear implantation (as
estimated by Barton et al., 2003). The incremental
costs of implantation incurred in the health sector,
in the education sector (Barton et al., 2006a), and by
the families of implanted children (Barton et al.,
2006b) were summed to estimate the incremental
societal cost of implantation. The gains in utility and
incremental costs associated with implantation
were assigned to the year of care in which they
arose. They were then accumulated for two periods
of time after implantation: (i) 15 yr and (ii) chil-
dren’s remaining life expectancy (Footnote 5).
Discounting • In line with recommendations for
economic analyses in the United Kingdom (Trea-
sury, Reference Note 4), future costs and benefits
were discounted at 3% per annum to reflect the fact
that people generally prefer to consume resources
now rather than in the future but prefer to defer
expenditure into the future rather than incurring it
now (Drummond et al., 1997). The year leading up
to, and including, implantation was enumerated as
the 0th year of care. No benefits were considered to
be obtained in that year. Benefits obtained in the
first year of care were discounted. Thus, the number
of QALYs gained from implantation was calculated
as
i1
n
u
1.03i, where n is the total number of years over
which benefits were accumulated and u is the dif-
ference in health utility between implanted and
nonimplanted children.
Costs incurred in the 0th year of care were not
discounted. Thus, the cost of implantation was calcu-
lated as
i0
n
ci
1.03i, where ci is the cost incurred in the i
th
year of care. A tutorial application of these techniques
to adult cochlear implantation was reported by the UK
Cochlear Implant Study Group (2004).
Cost-Effectiveness Analysis
Cost-effectiveness was estimated by dividing the
incremental societal cost of implantation by the num-
ber of QALYs gained from implantation to obtain the
incremental (societal) cost per QALY gained.
5 Life-expectancy data were obtained from the UK Government
Actuary’s Department (Government Actuary Department 2004,
Reference Note 3). Average levels of life expectancy, across boys
and girls, were calculated for a child implanted at age 3 yr and a
child implanted at age 6 yr. On average, both groups of children
were expected to live to age 79 yr, hence the average life
expectancy of the two groups was estimated to be 76 yr and 73 yr,
respectively (boys are estimated to have a life-expectancy 2 yr
below the average and girls 2 yr above the average). The life-
expectancy of children with cochlear implants does not differ
significantly from the life-expectancy of the age- and gender-
matched population (Summerfield & Marshall, 2001; Summer-
field, Cirstea, Roberts, Barton, Graham, & O’Donoghue, 2005).
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Analyses from Alternative Perspectives • To de-
termine whether conclusions were sensitive to the
perspective of the analysis, we compared results
obtained from the societal perspective with results
obtained from the perspectives of the health sector
alone, and the health and education sectors to-
gether. The second analysis also allowed compari-
sons with results reported by O’Neill et al. (2000)
and Schulze-Gattermann, et al. (2002).
Orientation of the Analyses
The modal age at implantation of children in the
sample was 3 yr, and the mean age at implantation
was 6 yr (Footnote 5). The average AHL of children
with implants was 115 dB (Stacey et al., 2006), with
93% of the sample (395 out of the 425 for whom AHL
data were available) having an AHL between 100 dB
and 130 dB (inclusive). To cover informative ranges
of AHL and age at implantation, we estimated the
costs, benefits, and cost-utility ratios associated
with implantation for children defined by the com-
bination of three AHLs (105 dB, 115 dB, and 125
dB), with two ages at implantation (3 and 6 yr).
RESULTS
Response Rate
Consent to participate was received from the
parents of 3274 children (37% of those invited to
participate). Questionnaires were returned by the
parents of 2858 of these children (88% of those who
consented to participate). The parents of 2266 chil-
dren (69% of those who consented to participate),
403 of whom had an implant, completed all sections
of the revised HUI3 questionnaire. Steps taken to
confirm the representativeness of the responding
sample were reported by Fortnum et al. (in press).
Health Utility
Average levels of health utility, without adjust-
ment for the effects of other variables, were lower for
children with less favorable AHLs (Table 2). The
average health utility of children with implants was
between that of severely and profoundly impaired
nonimplanted children.
Gain in Health Utility • Higher health utility was
associated with a more favorable AHL, an older age at
the onset of hearing impairment, female gender, hav-
ing fewer additional disabilities, having parents with a
greater occupational skill level and white ethnicity
(Table 3). In addition, implantation was associated
with a significant gain in health utility for five of the
six groups of implanted children. The nonsignificant
gain in health utility (for group 5) may be explained by
the fact that this group was composed of the smallest
number of children (N  25 out of 278 implanted
children). The largest gains were shown by children
who were implanted before the age of 5 yr who had
used their implants for more than 4 yr (Table 3).
When an interaction term between cochlear im-
plantation and preoperative AHL was added to the
TABLE 3. Coefficient values and 95% confidence intervals of
the variables used to predict health utility
Variable
Coefficient value
(95% CI)
Constant 0.622 (0.563 to 0.680)‡
Transformed average hearing level: 1.001 (0.910 to 1.093)‡
Age at onset of hearing impairment:
3 yr vs birth 0.068 (0.025 to 0.112)†
0 to 3 yr vs birth 0.039 (0.012 to 0.066)†
Age:
1 yr older 0.002 (–0.001 to 0.005)
Gender:
Female vs male 0.025 (0.006 to 0.045)*
Disabilities:
Two plus vs none –0.281 (–0.312 to –0.250)‡
One vs none –0.086 (–0.112 to –0.059)‡
POSL:
4 (highest) vs 1 (lowest) 0.049 (0.014 to 0.084)†
3 vs 1 0.026 (–0.006 to 0.058)
2 vs 1 0.034 (0.000 to 0.067)*
Ethnicity:
White vs other 0.034 (0.001 to 0.068)*
Parental Hearing:
No problems vs some problems 0.007 (–0.024 to 0.038)
Cochlear implantation:
Group 1 vs no implant 0.232 (0.184 to 0.280)‡
Group 2 vs no implant 0.183 (0.126 to 0.239)‡
Group 3 vs no implant 0.212 (0.161 to 0.263)‡
Group 4 vs no implant 0.172 (0.103 to 0.240)‡
Group 5 vs no implant 0.066 (–0.013 to 0.144)
Group 6 vs no implant 0.130 (0.053 to 0.206)‡
Adjusted r2  0.38; F-ratio  47.58 (p  0.001), 1490 children (278 of which had implants)
were included in the analysis (* p  0.05, † p  0.01, ‡ p  0.001).
TABLE 2. Estimated levels of health utility for five groups of hearing-impaired children
Group
Moderate
(AHL 40–70 dB)
Severe
(AHL 71–95 dB)
Profound
(AHL 96–105 dB)
Profound
(AHL 105 dB) Implanted
HUI3 score 0.677 0.616 0.497 0.353 0.575
(95% CI) (0.652–0.702) (0.598–0.634) (0.469–0.525) (0.327–0.379) (0.553–0.598)
N 260 464 259 290 403
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analysis, implantation was associated with a signif-
icantly larger gain in health utility for children with
a worse preoperative AHL (Table 4). For example,
after adjusting for other variables, the mean gain in
health utility (compared with non-implanted chil-
dren) for a child implanted at age 3 yr, for more than
four years, with a preoperative loss of 125 dB was
estimated to be 0.297, and 0.171 for a corresponding
child with a preoperative loss of 105 dB. This result
arose because health utility declined with worsening
AHL among children without cochlear implants but
was unrelated to AHL among implanted children.
Gain in QALYs
Similar variation according to preoperative AHL,
age at implantation, and duration of implant use was
found when these gains in health utility were accumu-
lated over time to estimate both the 15-yr and lifetime
QALY gains associated with implantation. Because
the gain in QALYs associated with implantation was
derived from the gain in health utility, larger gains in
QALYs were associated with a worse preoperative
AHL (e.g., 3.254 QALYs at 125 dB, compared with
1.843 QALYs at 105 dB, for a child implanted at age 3
yr, over a period of 15 yr), a younger age at implanta-
tion, and a longer duration of implant use (Table 4).
Incremental Costs
Health Sector • Over 15 yr it was estimated that
€1908 would be averted, on average, due to reduced
provision of acoustic hearing aids. The mean incre-
mental health sector cost of implantation was
thereby estimated to be €79,263 over a period of
15 yr (Table 5). Over a child’s lifetime, incremental
health sector costs were estimated to be €132,040 for
a child implanted at age 3 yr and €131,292 for a child
implanted at age 6 yr (Table 5).
Education Sector • Barton et al. (2006a) esti-
mated that implantation is associated with a nega-
tive incremental cost (i.e., a cost-saving) in educa-
tion for children with preoperative AHLs that
exceed 98 dB. Cost-savings were estimated to be
larger for children with worse preoperative AHLs.
The mean cumulative education cost-saving for a
child with a preoperative loss of 115 dB was esti-
mated to be €33,022 after implantation at age 3 yr,
and €22,853 after implantation at age 6 yr (Table 5).
EconomicCosts Incurred by theFamily • Barton
et al. (2006b) estimated that implantation is associ-
ated with an increase in the overall economic cost
incurred by the family but that these costs did not
vary according to preoperative AHL. The mean
cumulative economic cost was estimated to be €3355
for a child implanted at age 3 yr, and €949 for a child
implanted at age 6 yr (Table 5).
Societal Costs • When the health sector costs,
cost-savings in education, and economic costs in-
curred by the family were combined, lifetime incre-
mental societal costs were estimated to range be-
tween €92,525 (for a child with a preoperative loss of
125 dB, implanted at age 3 yr) and €119,591 (for a
child with a preoperative loss of 105 dB, implanted
at age 3 yr) (Table 5).
Cost-Effectiveness Analysis
The incremental societal cost of gaining a QALY
for a child with the average AHL (115 dB) implanted
at the average age of 6 yr was estimated to be
€25,629, when costs and benefits are accumulated
TABLE 4. Gains in health utility and in QALYs associated with cochlear implantation as a function of preoperative AHL, age at
implantation, and the time period over which gains are accumulated
Pre-operative
AHL(dB) Time period Variable
Gain in variable for children
implanted at age 3 yr
(95% CI)
Gain in variable for children
implanted at age 6 yr
(95% CI)
105 2 yr use Health utility 0.066 (–0.012 to 0.144) 0.115 (0.212 to 0.208)*
2–4 yr use Health utility 0.174 (0.113 to 0.234)‡ 0.172 (0.076 to 0.269)‡
4 yr use Health utility 0.171 (0.109 to 0.223)‡ 0.138 (0.046 to 0.229)†
15 yr total QALYs 1.843 1.661
Lifetime total QALYs 4.894 4.073
115 2 yr use Health utility 0.125 (0.029 to 0.221)* 0.156 (0.068 to 0.244)†
2–4 yr use Health utility 0.249 (0.194 to 0.304)‡ 0.185 (0.113 to 0.234)‡
4 yr use Health utility 0.256 (0.207 to 0.305)‡ 0.196 (0.139 to 0.252)‡
15 yr total QALYs 2.791 2.238
Lifetime total QALYs 7.363 5.668
125 2 yr use Health utility 0.153 (0.037 to 0.270)† 0.176 (0.056 to 0.295)†
2–4 yr use Health utility 0.286 (0.216 to 0.355)‡ 0.191 (0.097 to 0.284)‡
4 yr use Health utility 0.297 (0.238 to 0.357)‡ 0.224 (0.153 to 0.294)‡
15 yr total QALYs 3.254 2.520
Lifetime total QALYs 8.569 6.447
Significant gains in health utility are denoted by * p  0.05, † p  0.01, ‡ p  0.001.
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over 15 yr. This figure was calculated by dividing the
estimated incremental societal cost (€57,359) in Table
5 by the incremental QALY gain (2.238) in Table 4.
The incremental cost of gaining a QALY is lower the
worse the AHL, the younger the age at implanta-
tion, and the longer the period of time over which
costs and benefits are accumulated (Table 6). The
dependency on AHL arises because implanted chil-
dren with worse AHLs gain more utility and achieve
greater cost-savings in education, relative to non-
implanted children, than implanted children with
better AHLs do. The dependency on age at implan-
tation arises because the younger the age at implan-
tation, the greater the estimated QALY gain associ-
ated with implantation, and the greater the number
of years over which cost-savings in education can be
realized. The dependency on duration of use arises
because the QALY gain associated with implanta-
tion increases with duration of implant use, whereas
the annual costs associated with implantation fall.
Together, these effects result in cost/QALY esti-
mates which vary by nearly a factor of four from
€10,798/QALY for a lifetime of use by a child with an
AHL of 125 dB implanted at age 3 to €40, 660/QALY
for 15 yr of use by a child with an AHL of 105 dB
implanted at age 6.
Analyses from Alternative Perspectives
Our main conclusions—that implantation was
acceptably cost-effective, and more favorable when
estimated over a child’s lifetime, for children with a
worse preoperative AHL, and for children who were
implanted when younger—are not affected by the
perspective of the analysis. The same conclusions
are reached when cost-effectiveness is assessed from
the perspective of the health sector alone (Table 7)
or from the combined perspectives of the health and
education sectors (Table 8). These comparisons dem-
onstrate that the incremental health sector costs
and QALY gains are the main determinants of the
cost-effectiveness of pediatric implantation in the
United Kingdom.
DISCUSSION
The health utility of hearing-impaired children,
estimated with a modified version of the HUI3
TABLE 5. Costs associated with pediatric cochlear implantation
AHL (dB) Cost sector Time period
Implanted at
age 3 yr
Implanted at
age 6 yr
105 Health 15 yr €79,263 €79,263
Health Lifetime €132,040 €131,292
Education 15 yr –€15,804 –€12,676
Education Lifetime –€15,804 –€12,676
Family 15 yr €3,355 €949
Family Lifetime €3,355 €949
Societal 15 yr €66,814 €67,536
Societal Lifetime €119,591 €119,565
115 Health 15 yr €79,263 €79,263
Health Lifetime €132,040 €131,292
Education 15 yr –€33,022 –€22,853
Education Lifetime –€33,022 –€22,853
Family 15 yr €3,355 €949
Family Lifetime €3,355 €949
Societal 15 yr €49,596 €57,359
Societal Lifetime €102,373 €109,388
125 Health 15 yr €79,263 €79,263
Health Lifetime €132,040 €131,292
Education 15 yr –€42,870 –€29,669
Education Lifetime –€42,870 –€29,669
Family 15 yr €3,355 €949
Family Lifetime €3,355 €949
Societal 15 yr €39,748 €50,543
Societal Lifetime €92,525 €102,572
Positive entries are costs incurred. Negative entries are costs averted.
TABLE 6. Estimates of the societal cost per QALY associated
with pediatric cochlear implantation
AHL (dB) Time period
Implanted at
age 3 yr
Implanted at
age 6 yr
105 15 yr €36,253 €40,660
Lifetime €24,436 €29,355
115 15 yr €17,770 €25,629
Lifetime €13,904 €19,299
125 15 yr €12,215 €20,057
Lifetime €10,798 €15,910
Entries in bold are within the inferred limit for good value for money of €15,000 per QALY;
all other entries are within inferred acceptable limits of cost-effectiveness (between
€15,000 and €50,000 per QALY).
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questionnaire, varies systematically with variables
related to the child (average hearing level, age at
onset of hearing impairment, gender, and number of
additional disabilities) and the family (parental oc-
cupational skill level and ethnicity). After adjusting
for the effects of these variables, cochlear implanta-
tion is associated with a significant gain in health
utility. When estimates of the QALY gain associated
with implantation are compared with estimates of
the incremental societal cost of implantation, it was
estimated that implantation was acceptably cost-
effective, and more favorable when estimated over a
child’s lifetime, for children with a worse preopera-
tive AHL, and for children who were implanted
when younger. These findings are consistent with
the benefits of cochlear implantation that have been
found in the domains of speech perception, everyday
communication, and educational attainment, for the
same sample of children (Stacey et al., 2006).
Comparisons with Other Studies
Health Utility • The gain in health utility asso-
ciated with implantation was estimated to be higher
for children implanted younger, with a worse preop-
erative AHL, and to increase (though at a margin-
ally decreasing rate) with duration of implant use (3
and 4). For children with the mean AHL of the
sample (115 dB), implantation was associated with a
mean gain in health utility which varied from 0.13
to 0.26, depending on the age of the child at
implantation and the duration of implant use. These
values straddle the gain of 0.20, which was mea-
sured, also using the HUI3 questionnaire, in two
studies of adults (Palmer, Niparko, Wyatt, Rothman,
& de Lissovoy, 1999; UK Cochlear Implant Study
Group, 2004), and which has been adopted as the
starting point in some studies of children (Hutton et
al., 1995; O’Neill et al., 2000; Summerfield & Mar-
shall, 1995; Summerfield et al., 1997).
Our estimates are lower, however, than the gain
of 0.39 estimated by Cheng et al. (2000) when
parents completed the HUI3 questionnaire retro-
spectively for their children. Possibly, Cheng et al.
(2000) recorded a higher estimate because of recall
bias associated with retrospective data collection
(Dawson et al., 2002). In a meta-analysis of seven
studies which estimated the gain in quality of life
associated with implantation for adults (Cheng &
Niparko, 1999), the four largest gains came from the
four studies which used retrospective methods. Ad-
ditionally, our revisions to the questionnaire may
also account for part of the difference. An alternative
interpretation is that parents who have witnessed a
change in their child’s health utility may be sensi-
tized to the states described in the HUI3 question-
naire and may make more accurate judgments as a
result.
Societal Costs • Three previous studies (Cheng et
al., 2000; O’Neill et al., 2000; Schulze–Gattermann
et al., 2002) have estimated the incremental cost of
pediatric cochlear implantation in domains outside
the health sector. From the viewpoint of the health
and education sectors together, the incremental cost
has been estimated to be €55,133 (exchange rate US
$1.20 €1.00) in the United Kingdom (O’Neill et al.,
2000; 1997/8 prices, 6% discount rate), between
€46,000 and €57,000 in Germany (up to age 16 yr)
(Schulze–Gattermann et al., 2002; 1999 prices, 6%
discount rate), and equivalent to a cost saving of US
$5,330 (€4,442) in the United States (Cheng et al.,
2000; 1999 prices, 3% discount rate). These esti-
mates are lower than our summation of the lifetime
incremental costs in the health and education sec-
tors, which range between €89,170 (for a child im-
planted at age 3, with a preoperative loss of 125 dB)
and €118,616 (for a child implanted at age 6, with a
preoperative loss of 105 dB) (Table 5). Part of this
difference can be explained by the fact that we used
more recent price levels and a lower discount rate
(2001/2 and 3%) than O’Neill et al. (2000) (1997/8
and 6%) and Schulze-Gattermann et al. (2002) (1999
and 6%). Additionally, Cheng et al. (2000) and
O’Neill et al. (2000) based their estimates of hospital
TABLE 7. Estimates of the cost per QALY associated with
pediatric cochlear implantation from the perspective of the
health sector
AHL (dB) Time period
Implanted at
age 3 yr
Implanted at
age 6 yr
105 15 yr €43,008 €47,723
Lifetime €26,982 €32,235
115 15 yr €28,399 €35,413
Lifetime €17,933 €23,164
125 15 yr €24,358 €31,452
Lifetime €15,410 €20,366
All entries are within inferred acceptable limits of cost-effectiveness (between €15,000 and
€50,000 per QALY).
TABLE 8. Estimates of the cost per QALY associated with
pediatric cochlear implantation from the perspectives of the
health and education sectors combined
AHL (dB) Time period
Implanted at
age 3 yr
Implanted at
age 6 yr
105 15 yr €34,433 €40,091
Lifetime €23,752 €29,123
115 15 yr €16,568 €25,203
Lifetime €13,448 €19,132
125 15 yr €11,184 €19,679
Lifetime €10,407 €15,764
Entries in bold are within the inferred limit for good value for money of €15,000 per QALY,
all other entries are within inferred acceptable limits of cost-effectiveness (between
€15,000 and €50,000 per QALY).
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costs on medical reimbursement levels, which have
been argued to underestimate the true hospital costs
of implantation (Cheng & Niparko, 1999; Cheng et
al., 2000; Garber, et al., 2002; Summerfield et al.,
2003). Additionally, Barton et al. (2006a) demon-
strated that our estimates of the educational cost-
savings associated with implantation may be
smaller than those reported by Cheng et al. (2000)
and O’Neill et al. (2000) because we controlled for
more confounding variables.
Cost-Effectiveness • We estimate that the incre-
mental life-time health sector cost/QALY of provid-
ing implants to children ranges from €15,410 (for a
child implanted at age 3, with a preoperative loss of
125 dB) to €47,723 (for a child implanted at age 6,
with a preoperative loss of 105 dB). The only other
study which has based estimates of the cost-effec-
tiveness of pediatric cochlear implantation on mea-
sures of health utility for children is the US study
reported by Cheng et al. (2000). Their estimates of
the cost/QALY were lower than ours and ranged
between US$5,197 (€4331) and US$9,209 (€7674)
(1999 prices). The difference may be explained, in
part, by the factors discussed in the previous
paragraph.
In contrast, our results agree more closely with
other UK estimates (Summerfield et al., 1997;
O’Neill et al., 2000), provided that analyses con-
ducted in earlier years are brought into alignment
by inflating costs to the same year (2001/2) and
adopting the same discount rate (3% per annum).
When we adopt those parameters, we estimate that
implantation of a child with a preoperative loss of
115 dB achieves a lifetime health sector cost/QALY
of between €17,933 (for implantation at age 3) and
€23,164 (for implantation at age 6), compared with
€27,745 (Summerfield et al., 1997) and €26,314
(O’Neill et al., 2000).
Limitations
One limitation of the present study is that our
estimates of costs and benefits were derived from
regression analyses of cross-sectional data, rather
than from prospective data for individual children
who had been randomized either to receive, or not
receive, an implant. Given the challenge of obtaining
parental consent to randomization and compliance
with randomization, we chose not to undertake a
randomized study (Summerfield, 2002). As a result,
we cannot be certain that we controlled every vari-
able that influenced whether or not a child had
received an implant. Also, our estimates of the gain
in utility at different times after implantation are
based on the gains displayed by different groups of
children at one point in time, rather than the gains
displayed by a single group of children at successive
points in time. Children implanted at different
points in time may receive different implant devices
and different care from implant programs, or differ
in other ways from children implanted at other time
points. Though we controlled many characteristics
of the child and family, we did not control all of these
variables.
A second limitation arises in our estimation of
health utility. Our estimates were obtained by pa-
rental proxy, and with a nonstandard version of the
HUI3 questionnaire. Our resulting estimate of the
gain in health utility associated with implantation is
smaller than that of the one study that used the
standard HUI3 questionnaire (Cheng et al., 2000),
also by parental proxy, albeit with a retrospective
design without controls. In our study only parents
were asked to estimate the health utility of their
child, other measures (e.g., quality of life and edu-
cational attainment) were however estimated both
by parents and by teachers. Stacey et al. (2006) have
shown that there was broad agreement between the
estimates of parents and teachers on such measures,
thereby suggesting that the method of obtaining
health utility estimates by parental proxy is a reli-
able one.
A third limitation is that we did not assess the
impact of all relevant variables on the cost-effective-
ness of implantation. Our results are based largely
on children who were implanted before the year
2000, and we therefore did not assess, as other
papers have (O’Neill et al. 2002; Sach et al., 2003),
whether the cost-effectiveness of implantation has
improved over time. Similarly, we did not investi-
gate whether the incremental health sector costs of
implantation varied according to clinical and demo-
graphic characteristics of children. Were they found
to do so then this would, in turn, further influence
estimates of the cost-effectiveness of implantation.
In addition, only 7% of the children in our sample
had a preoperative loss that was less than 100 dB
(29 out of the 425 children for whom a value of AHL
was available), and only 14% were implanted before
the age of 3 yr. As a result, we cannot estimate the
cost-effectiveness of implantation for children with a
preoperative loss of 100 dB, nor can we assess the
health-economic implications of the recommenda-
tion that congenitally hearing-impaired children
should, where possible, be implanted before the age
of 2 yr (Francis & Niparko, 2003). Trends in our data
do suggest however that the results could be less
favorable for children with a preoperative loss of
100 dB, and more favorable for children implanted
before the age of 2 yr. These limitations, coupled
with a critical mass of studies which have concluded
that pediatric implantation is acceptably cost-effec-
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tive (e.g., Cheng et al., 2000; O’Neill et al., 2000;
Summerfield et al., 1997), mean that future studies
should concentrate on the current point of clinical
equipoise by recruiting children who use state-of-
the-art implant systems, with AHLs 100 dB, and
who are implanted before the age of 2 yr.
A fourth limitation is that we have defined can-
didacy in the unidimensional metric of average
unaided preoperative hearing level, whereas the
metric used in clinical practice is multidimensional
and also includes the ability, or potential, to benefit
from acoustic hearing aids. Therefore, the conclu-
sion that estimates of the cost-effectiveness of pedi-
atric cochlear implantation were more favorable for
children with a worse preoperative AHL should be
treated only as a broad indication of a criterion of
candidacy. Failure to take account of other poten-
tially explanatory variables may be why only 38% of
the variation in health utility could be explained
within our analysis (see Table 5). The same explan-
atory variables were able to explain 70% of the
variation in children’s academic abilities (Stacey et
al., 2006).
A final limitation stems from the desirability of
basing estimates of cost-effectiveness on measures
of social preference obtained from the same general
population as the one from which patients are
drawn (NICE, 2004). The use of the HUI3 in the
present study violates this principle. The HUI3
measures the utility of states of health based on
preferences expressed by a sample of the population
of Ontario, Canada. We applied their preferences to
children treated in the United Kingdom. Thus,
pending a UK valuation of the health states in the
HUI3 (c.f. McCabe, Stevens, Roberts, & Brazier,
2005), we cannot judge whether the absolute values
of our estimates of cost-effectiveness are appropriate
for the United Kingdom. We can be more confident
in the relative values of our estimates, however,
because a re-evaluation of the HUI3 for the United
Kingdom would be more likely to cause the cost-
effectiveness of different implant groups to shift in
the same direction, rather than to move relative to
one another. More weight can be given, therefore, to
the conclusion that implantation is most cost-effec-
tive when implants are provided to children with a
worse AHL at the youngest age, than to the idea
that implantation represents good or poor value for
money for any particular group of candidates.
To set against these limitations, the design of the
study allowed adjustment for effects of many con-
founding variables when estimating the association
between implantation and health utility. Moreover,
a relatively large proportion of the variation in
health utility could be explained, compared with
that achieved when undertaking similar analyses
with two components of the societal cost of implan-
tation: costs of education (Barton et al., 2006a) and
the economic costs incurred by the family (Barton et
al., 2006b). The credibility of the results is further
bolstered by the fact that cost-effectiveness estimates
are based on data from a representative sample of UK
population of hearing-impaired children.
CONCLUSIONS
The provision of cochlear implants to children has
been controversial because of high costs, uncertain
outcomes, and doubts about the ethics of performing
surgery on a healthy child. This article, and three
companion articles (Stacey et al., 2006; Barton et al.,
2006a; 2006b), have addressed the first two concerns
in controlled comparisons of implanted and nonim-
planted children. We have shown that implantation
is associated with significant improvements in spo-
ken communication skills and in some aspects of
educational achievements and quality of life, pro-
vided that children receive implants before the age
of 5 yr (Stacey et al., 2006). These benefits are
accompanied by reduced costs of education (Barton
et al., 2006a), but with modestly increased costs
incurred by families (Barton et al., 2006b). The
present paper adds to these findings by showing
that the health utility benefits of providing implan-
tation to deaf children are significant. In addition,
the benefits are estimated to be large enough to have
justified the costs, and to be greatest for children
with a greater preoperative loss of hearing and for
children who are younger.
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